PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAbeona Therapeutics
Abeona Therapeutics(ABEO)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Prademagene zamikeracel
epidermolysis bullosa
,
epidermolysis bullosa dystrophica
Bevifimod
allergic rhinitis seasonal
,
nasal obstruction
,
sneezing
,
dental anxiety
,
restless legs syndrome
,
spinal cord injuries
,
type 1 diabetes mellitus
,
hiv infections
,
non-small-cell lung carcinoma
,
osteoarthritis
,
breast neoplasms
,
depression
,
neurologic manifestations
,
wounds and injuries
,
central nervous system diseases
,
spinal cord diseases
,
sleep wake disorders
,
inguinal hernia
,
peripheral nervous system diseases
,
radiculopathy
,
psoriasis
,
fibromyalgia
,
healthy volunteers/patients
,
neuralgia
,
partial epilepsies
,
diabetic neuropathies
,
epilepsy
,
pain
,
sleep initiation and maintenance disorders
,
seizures
,
postherpetic neuralgia
,
postoperative pain
,
anxiety disorders
,
low back pain
,
generalized anxiety disorder
,
complex partial epilepsy
,
back pain
,
breast feeding
,
bronchiolitis obliterans syndrome
,
neoplasms
,
bone neoplasms
,
intractable pain
,
phantom limb
,
burns
,
renal insufficiency
,
pharmacovigilance
Fluoroquinolone
anemia
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use